Open AccessEstimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission
Author(s) -
Ashish Goyal,
Matthew R. Gardner,
Bryan T. Mayer,
Keith R. Jerome,
Michael Farzan,
Joshua T. Schiffer,
E. Fabián Cardozo-Ojeda
Publication year - 2022
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abj5666
Subject(s) - potency , term (time) , neutralization , in vivo , estimation , ex vivo , production (economics) , medicine , immunology , computational biology , computer science , virology , biology , in vitro , microbiology and biotechnology , antibody , genetics , economics , physics , management , macroeconomics , quantum mechanics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom